Biotechnology Epitope Binning Powered By LENSai TM Technology Can Analyze Over 5,000 Sequences With No Physical Materials Needed, Matches Classical Wet Lab Binning Results – ImmunoPrecise Antibodies (NASDAQ:IPA) Read more
Biotechnology ImmunoPrecise Antibodies And InterSystems Partner To Leverage AI In Life Sciences, Transforming Patient Care With Accelerated Discovery And Delivery Of Treatments – ImmunoPrecise Antibodies (NASDAQ:IPA) Read more
Biotechnology EXCLUSIVE: Immunoprecise Antibodies and InterSystems Integrate Vector Search With LENSai For AI-Driven Healthcare Applications – ImmunoPrecise Antibodies (NASDAQ:IPA) Read more
Biotechnology ImmunoPrecise Antibodies (NASDAQ: IPA) Subsidiary BioStrand Introduces Breakthrough AI Model In Life Sciences, Harnessing LLM Stacking And HYFT Technology – ImmunoPrecise Antibodies (NASDAQ:IPA) Read more
Biotechnology The “Hub” Of Biotherapuetic Intelligence – This Company Utilizes Powerful AI – ImmunoPrecise Antibodies (NASDAQ:IPA) Read more
Biotechnology ImmunoPrecise Antibodies (NASDAQ: IPA) Is Changing How We Look At The Complex World Of Antibody Discovery – ImmunoPrecise Antibodies (NASDAQ:IPA) Read more
